Literature DB >> 9327434

Flow cytometry applications in pharmacodynamics and drug delivery.

M Ramanathan1.   

Abstract

We highlight recent advances in flow cytometry that have potential applications in the pharmaceutical sciences, particularly in pharmacodynamics and drug delivery. These advances are discussed in the context of the preclinical development of anticancer agents, immunosuppressants and immunomodulators, and oligonucleotides and gene therapy.

Mesh:

Substances:

Year:  1997        PMID: 9327434     DOI: 10.1023/a:1012178001348

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  60 in total

Review 1.  Drug delivery issues in vaccine development.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

2.  T cell activation via Leu-23 (CD69).

Authors:  R Testi; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

3.  Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.

Authors:  M S Dordal; A C Ho; M Jackson-Stone; Y F Fu; C L Goolsby; J N Winter
Journal:  Cytometry       Date:  1995-08-01

Review 4.  Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry.

Authors:  W G Telford; L E King; P J Fraker
Journal:  J Immunol Methods       Date:  1994-06-03       Impact factor: 2.303

5.  Green fluorescent protein as a marker for gene expression.

Authors:  M Chalfie; Y Tu; G Euskirchen; W W Ward; D C Prasher
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

6.  Calibration of flow cytometer detector systems.

Authors:  R E Durand
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

7.  Rapid flow cytometric method for measuring lymphocyte subset activation.

Authors:  V C Maino; M A Suni; J J Ruitenberg
Journal:  Cytometry       Date:  1995-06-01

8.  Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment.

Authors:  A H Wyllie; R G Morris
Journal:  Am J Pathol       Date:  1982-10       Impact factor: 4.307

9.  Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors.

Authors:  Q Zhao; T Waldschmidt; E Fisher; C J Herrera; A M Krieg
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

10.  A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients.

Authors:  N Testoni; G Martinelli; P Farabegoli; A Zaccaria; M Amabile; D Raspadori; S Pelliconi; E Zuffa; C Carboni; S Tura
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  1 in total

1.  Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells.

Authors:  M Wirth; A Fuchs; M Wolf; B Ertl; F Gabor
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.